Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

Zimmerman AW, Joosten B, Torensma R, Parnes JR, van Leeuwen FN, Figdor CG.

Blood. 2006 Apr 15;107(8):3212-20. Epub 2005 Dec 13.

2.
3.

Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions.

Bowen MA, Aruffo A.

Transplant Proc. 1999 Feb-Mar;31(1-2):795-6. Review. No abstract available.

PMID:
10083342
4.

Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.

Bowen MA, Aruffo AA, Bajorath J.

Proteins. 2000 Aug 15;40(3):420-8. Review.

PMID:
10861932
5.

The dynamics of dendritic cell-T cell interactions in priming and tolerance.

Hugues S, Boissonnas A, Amigorena S, Fetler L.

Curr Opin Immunol. 2006 Aug;18(4):491-5. Epub 2006 Jun 12. Review.

PMID:
16765575
6.

Decoding the dynamics of T cell-dendritic cell interactions in vivo.

Celli S, Garcia Z, Beuneu H, Bousso P.

Immunol Rev. 2008 Feb;221:182-7. doi: 10.1111/j.1600-065X.2008.00588.x. Review.

PMID:
18275482
7.

CD6 as a therapeutic target in autoimmune diseases: successes and challenges.

Pinto M, Carmo AM.

BioDrugs. 2013 Jun;27(3):191-202. doi: 10.1007/s40259-013-0027-4. Review.

PMID:
23568178
8.

CD6-ligand interactions: a paradigm for SRCR domain function?

Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA, Bajorath J.

Immunol Today. 1997 Oct;18(10):498-504. Review.

PMID:
9357143
9.

Adhesion molecules in human dendritic cells.

Rodríguez-Fernández JL, Corbí AL.

Curr Opin Investig Drugs. 2005 Nov;6(11):1103-11. Review.

PMID:
16312130
10.

Dendritic cells and autoimmunity.

Bayry J, Thirion M, Delignat S, Misra N, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Autoimmun Rev. 2004 Mar;3(3):183-7. Review.

PMID:
15110229
11.

Semaphorins in interactions between T cells and antigen-presenting cells.

Kikutani H, Kumanogoh A.

Nat Rev Immunol. 2003 Feb;3(2):159-67. Review.

PMID:
12563299
12.

Cell adhesion and polarity during immune interactions.

Montoya MC, Sancho D, Vicente-Manzanares M, Sánchez-Madrid F.

Immunol Rev. 2002 Aug;186:68-82. Review.

PMID:
12234363
13.

ALCAM/CD166: cancer-related issues.

Weidle UH, Eggle D, Klostermann S, Swart GW.

Cancer Genomics Proteomics. 2010 Sep-Oct;7(5):231-43. Review.

PMID:
20952758
14.

T-cell recognition of antigen. A process controlled by transient intermolecular interactions.

Boniface JJ, Davis MM.

Ann N Y Acad Sci. 1995 Sep 7;766:62-9. Review.

PMID:
7486700
15.

DCs as targets for vaccine design.

Belz G, Smith C, Bharadwaj M, Rice A, Jackson D.

Cytotherapy. 2004;6(2):88-98. Review.

PMID:
15203984
16.

The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics.

Lanzavecchia A, Sallusto F.

Curr Opin Immunol. 2001 Jun;13(3):291-8. Review.

PMID:
11406360
17.

Clinical and experimental evidence for targeting CD6 in immune-based disorders.

Consuegra-Fernández M, Lin F, Fox DA, Lozano F.

Autoimmun Rev. 2018 May;17(5):493-503. doi: 10.1016/j.autrev.2017.12.004. Epub 2018 Mar 9. Review.

PMID:
29526637
19.

Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses.

Santos RF, Oliveira L, Carmo AM.

Curr Drug Targets. 2016;17(6):630-9. Review.

PMID:
26028048
20.

The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.

Kofler DM, Farkas A, von Bergwelt-Baildon M, Hafler DA.

Curr Drug Targets. 2016;17(6):651-65. Review.

PMID:
26844569

Supplemental Content

Support Center